| Financial Year |
March 31 2023 |
| Monetary Funds |
579,882,747.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,005,443.67 |
| Accounts Receivable |
118,771,855.49 |
| Advances to Suppliers |
3,245,796.72 |
| Other Receivables |
771,002.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
59,523,552.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
256,516,753.79 |
| Total Current Assets |
1,019,789,151.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
174,891,178.63 |
| Fixed Assetes |
3,204,646.16 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
130,928.72 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,810,308.17 |
| Deferred Income Tax Assets |
17,000,560.80 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
201,019,172.62 |
| Total Assets |
1,220,808,323.73 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
955,112.48 |
| Accounts Payable |
50,413,123.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,544,540.62 |
| Taxes Payable |
1,527,012.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,579,223.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,911,619.36 |
| Other Current Liabilities |
889,097.78 |
| Sub-Total of Current Liabilities |
76,430,544.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,472,645.83 |
| Deferred Income Tax Liabilities |
2,667,293.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,263,965.81 |
| Total Liabilities |
83,694,510.13 |
| Paid-In Capital(Or Share Stock) |
282,880,000.00 |
| Capital Surplus |
957,852,307.70 |
| Surplus Reserve |
33,654,443.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-126,560,717.13 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,137,113,813.60 |
| Owner's Equity（Stockholder's Equity） |
1,137,113,813.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,220,808,323.73 |
